Just in time for the holidays – and the growing season – the U.S. Environmental Protection Agency (EPA) has granted new registrations for pesticides to be used on hemp crops, including, for the first time, hemp used in the production
Continue Reading Happy Hemp-days! EPA Grants First Ever Approvals for Pesticides Used on Hemp for Consumable CBD Products

On the latest episode of the Ad Law Access Podcast, partner Kristi Wolff discusses FDA’s recent CBD warning letters, Commissioner nominee Dr. Stephen Hahn’s confirmation hearings, and a preview of this week’s Cannabis Law Update webinar.

On Thursday, December
Continue Reading Podcast: CBD Warning Letters, FDA Commissioner Confirmation Hearing and Preview of Upcoming Webinar

On October 12, 2019, California Governor Gavin Newsom announced the following cannabis-related bills were signed into law:

  • AB 37
    • Allows cannabis businesses to claim state tax deductions and credits available to other legal businesses in the state for each taxable


Continue Reading New California Cannabis-Related Bills Make it Off the Governor’s Desk

On 24 September, European regulators cleared the way for GW Pharma’s cannabinoid medicinal product to treat patients with two rare, severe forms of epilepsy. The European Commission approved Epidyolex to treat seizures associated with Lennox Gastaut syndrome (LGS) or Dravet
Continue Reading Navigating the Haze of Cannabis Rules and Regulations in Europe

Today, the FTC issued warning letters to three companies selling CBD products.  The companies, which FTC did not identify publicly, allegedly illegally advertised CBD products as being able to treat or cure serious diseases and health conditions without competent and
Continue Reading FTC Issues Warning Letters to Companies Advertising Their CBD-Infused Products as Treatments for Serious Diseases